Search Results
124 results
Your search is now limited to «FDA Actions» expert search.
FierceBiotech 03/20/2019 10:39
In the letter to J&J’s Mentor Worldwide and Acclarent units, the FDA said the companies had failed to meet enrollment milestones for recipients of its MemoryShape breast implant, which was approved in June 2013.
More from FierceBiotech:
GlobeNewswire 03/20/2019 03:00
Iclaprim has received Qualified Infectious Disease Product (QIDP) designation from the FDA together with Fast Track status for the ABSSSI indication.
More from GlobeNewswire:
MedCity News 03/15/2019 13:48
Earlier last week, the FDA had recommended that clinical trials in oncology let in more patients with HIV and hepatitis B and C. The guidance, announced Friday in the Federal Register and posted to the FDA’s website, was a finalization of draft guidance issued previously ...
More from MedCity News:
Public Health Newswire 03/14/2019 10:29
Check out today’s public health news for Thursday, Mar. 14, 2019.
More from Public Health Newswire:
FDLI SmartBrief 03/14/2019 09:56
New FDA draft guidance suggests the inclusion of patients with HIV, hepatitis B and hepatitis C in cancer clinical trials based on predetermined conditions.
More from FDLI SmartBrief:
PR Newswire 03/12/2019 10:19
These guidances provide recommendations on how sponsors can safely and effectively broaden the criteria for the inclusion of certain patient populations in clinical trials, when appropriate, for pediatric patients, and patients with Human Immunodeficiency Virus, Hepatitis B and Hepatitis C Virus Infections, brain metastases, prior or concurrent malignancies or organ dysfunction.
More from PR Newswire:
Healio News 03/08/2019 14:34
FDA accepts NDA for pretomanid in combination TB regimen.
More from Healio News:
The FDA is expected to make a decision on approval by November 4, 2019.
More from Global Banking & Finance Review:
Zero Hedge 03/05/2019 15:14
Gottlieb spent much of his confirmation hearing talking about the opioid epidemic – comparing it to public health emergencies caused by the Ebola and Zika viruses – while acknowledging the FDA’s own unwitting contribution by granting approvals for the painkillers.
More from Zero Hedge:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications